Boryung Pharm signs KRW 83 billion export agreement with Ram Pharma

Published: 2017-01-02 11:50:39

Updated: 2017-01-02 11:50:39

Boryung Pharm made an official announcement that it has signed an export contract of KRW 83 billion for Todula with Jordanian Ram Pharma. Todula is a calcium channel blocker(CCB) antihypertensive.

The agreement with Ram Pharma, a Jordanian company, involves with the total USD 68,839,144, including a USD 60,861,600 supply agreement, USD 5,477,544 running royalties and a USD 2,500,000 license fe...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.